The expanding role of prodrugs in contemporary drug design and development
@article{Rautio2018TheER, title={The expanding role of prodrugs in contemporary drug design and development}, author={Jarkko Rautio and Nicholas A. Meanwell and Li Di and Michael J. Hageman}, journal={Nature Reviews Drug Discovery}, year={2018}, volume={17}, pages={559-587} }
Prodrugs are molecules with little or no pharmacological activity that are converted to the active parent drug in vivo by enzymatic or chemical reactions or by a combination of the two. Prodrugs have evolved from being serendipitously discovered or used as a salvage effort to being intentionally designed. Such efforts can avoid drug development challenges that limit formulation options or result in unacceptable biopharmaceutical or pharmacokinetic performance, or poor targeting. In the past 10…
278 Citations
Prodrugs for Improved Drug Delivery: Lessons Learned from Recently Developed and Marketed Products
- Biology, ChemistryPharmaceutics
- 2020
Overall, the prodrug approach is a powerful tool to decrease the time/costs of developing new drug entities and improve overall drug therapy.
Recent Advances in Prodrug-based Nanoparticle Therapeutics.
- BiologyEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
- 2021
LATENTIATED PRODRUG APPROACH OF DRUGS: AN OVERVIEW
- BiologyInternational Journal of Applied Pharmaceutics
- 2021
The purpose of this review is to understand the prodrugs, strategies incorporated in designing the proDrugs, applications, their crucial benefits in targeted action at a specific site of the body, their advantageous effects in chemotherapy.
Design of BET Inhibitor Prodrugs with Superior Efficacy and Devoid of Systemic Toxicities
- Biology
- 2020
Through tuning of traceless linkers appended to a “brush prodrug” scaffold, it is demonstrated that it is possible to correlate in vitro prodrug activation kinetics with in vivo tumor pharmacokinetics, leading to novel BETi prodrugs with enhanced anti-tumor efficacy and devoid of dose-limiting toxicities.
The prospects of lipidic prodrugs: an old approach with emerging an future.
- Biology, ChemistryFuture medicinal chemistry
- 2019
Overall, lipidic prodrugs present a promising approach for overcoming different obstacles and fulfilling various unmet needs in drug delivery/targeting.
Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development
- Biology, ChemistryActa pharmaceutica Sinica. B
- 2022
Molecular Modeling-Guided Design of Phospholipid-Based Prodrugs
- Biology, ChemistryInternational journal of molecular sciences
- 2019
Computational simulation-guided PL-based prodrug molecular design correlates well with the experimental results, allowing for more mechanistic and less empirical development.
Carbamate Group as Structural Motif in Drugs: A Review of Carbamate Derivatives used as Therapeutic Agents
- Biology, ChemistryArhiv za higijenu rada i toksikologiju
- 2020
A brief review takes a look at the properties and use of carbamates in various fields of medicine and provides quick insights into the mechanisms of action for some of them.
Design of BET Inhibitor Bottlebrush Prodrugs with Superior Efficacy and Devoid of Systemic Toxicities.
- BiologyJournal of the American Chemical Society
- 2021
Prodrugs engineered for preferential activation in diseased versus normal tissues offer immense potential to improve the therapeutic indexes (TIs) of preclinical and clinical-stage active…
Engineering of small-molecule lipidic prodrugs as novel nanomedicines for enhanced drug delivery
- Biology, ChemistryJournal of Nanobiotechnology
- 2022
The rational design of SLPs in response to the physiological barriers of chemotherapeutic agents is highlighted, and their biomedical applications are also emphasized with special functions, followed by a brief introduction of the promising opportunities and potential challenges of SLP-based drug delivery systems (DDSs) in clinical application.
References
SHOWING 1-10 OF 284 REFERENCES
Prodrugs: design and clinical applications
- Biology, ChemistryNature Reviews Drug Discovery
- 2008
The most common functional groups that are amenable to prodrug design are described, and examples of prodrugs that are either launched or are undergoing human trials are highlighted.
Prodrugs as therapeutics
- Biology, Chemistry
- 2004
It appears that prodrugs to overcome barriers to the delivery of problematic drug candidates are becoming an integral part of the drug discovery paradigm.
Prodrugs—from Serendipity to Rational Design
- Biology, ChemistryPharmacological Reviews
- 2011
The rationale behind the use of the prodrug approach from past to present is introduced, and the possible problems that can arise from inadequate activation of prodrugs are considered.
Amino acids as promoieties in prodrug design and development.
- Biology, ChemistryAdvanced drug delivery reviews
- 2013
Prodrugs – Recent approvals and a glimpse of the pipeline
- Biology, MedicineEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
- 2017
Prodrugs: Some thoughts and current issues.
- Biology, ChemistryJournal of pharmaceutical sciences
- 2010
The prodrug approach to resolving formulation, delivery, and toxicity limitations on problematic drugs has had its proponents and detractors, and is becoming an integral part of the drug discovery paradigm in some large pharma companies.
Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.
- Biology, ChemistryCurrent medicinal chemistry
- 2010
This article is intended to encourage discovery scientists to be creative and consider a rationally designed prodrug approach during the lead optimization phase of drug discovery programs, when the structure activity relationship for the drug target is incompatible with pharmacokinetic or biopharmaceutical objectives.
Chemistry-enabled drug delivery (prodrugs): recent progress and challenges.
- Biology, ChemistryDrug discovery today
- 2014